Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
出版年份 2022 全文链接
标题
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
作者
关键词
-
出版物
Journal of Cystic Fibrosis
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2022-02-02
DOI
10.1016/j.jcf.2022.01.012
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease
- (2021) Pierre-Régis Burgel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study
- (2021) Ruth Marian Mitchell et al. THORAX
- Ethical dilemma: ELX/TEZ/IVA or Lung Transplantation in Cystic Fibrosis and End Stage Lung Disease?
- (2021) Oded Breuer et al. CHEST
- Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation
- (2021) Lorriana E. Leard et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Major Decrease in Lung Transplantation for Patients with Cystic Fibrosis in France
- (2021) Clémence Martin et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Re-Imagining Cystic Fibrosis Care: Next Generation Thinking
- (2020) Catherine Rang et al. EUROPEAN RESPIRATORY JOURNAL
- Cystic Fibrosis Foundation consensus guidelines for the care of individuals with advanced cystic fibrosis lung disease
- (2020) Siddhartha G. Kapnadak et al. Journal of Cystic Fibrosis
- Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines
- (2019) Kathleen J. Ramos et al. Journal of Cystic Fibrosis
- The future of cystic fibrosis care: a global perspective
- (2019) Scott C Bell et al. Lancet Respiratory Medicine
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
- (2019) Harry G M Heijerman et al. LANCET
- Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
- (2019) Peter G. Middleton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
- (2017) Jennifer L. Taylor-Cousar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Morphometric Analysis of Explant Lungs in Cystic Fibrosis
- (2016) Mieke Boon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Long-term computed tomographic changes in cystic fibrosis patients treated with ivacaftor
- (2016) Guillaume Chassagnon et al. EUROPEAN RESPIRATORY JOURNAL
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival Benefit of Lung Transplant for Cystic Fibrosis since Lung Allocation Score Implementation
- (2013) Gabriel Thabut et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now